idelalisib
thioguanine
chloraminophene
venetoclax
ponatinib
antileukemic
pegaspargase
tyrosine kinase inhibitor
alemtuzumab
acute lymphoblastic leukemia
tafasitamab
promyeloleukemia
ubenimex
roscovitine
acalabrutinib
506U78
alvocidib
fludarabine
axicabtagene ciloleucel
axicabtagene
lumiliximab
vosaroxin
olutasidenib
asparaginase
Elspar
leukemogenicity
trilaciclib
cytarabine
midostaurin
ofatumumab
lymphohyperplasia
omacetaxine
capmatinib
mogamulizumab
piposulfan
rituximab
afutuzumab
lymphocytoma
cytotoxic drug
vismodegib
umbralisib
monalizumab
ivosidenib
ceritinib
acute lymphocytic leukemia
clofarabine
rubitecan
lymphocytic leukemia
thiotepa
chemodrug
bortezomib
leucocrit
leucoblastoma
lymphoblast
lymphoblastic leukemia
migrastatic
lenzilumab
lymphosuppression
folinic acid
leucovorin
mannosulfan
mafosfamide
chronic lymphocytic leukemia
dacarbazine
hematogone
lymphoblastoid
leukemogenesis
asciminib
immunokinase
loncastuximab tesirine
talacotuzumab
aracytine
immunocytometry
acute leukemia
picoplatin
EPOCH
cryptolepine
acasunlimab
tazemetostat
osimertinib
achroacytosis
homoharringtonine